Description
Retatrutide is an experimental 39-amino-acid synthetic peptide engineered with a fatty diacid moiety to enable extended half-life through albumin binding. As a novel triple agonist, it simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. Research focuses on its multi-pathway activation to enhance glycemic control, delay gastric emptying, increase lipid oxidation, and elevate energy expenditure.
| Technical Specification | Details |
| Product Name | Retatrutide |
| Available Sizes & Prices | 10 mg ($149) | 20 mg ($249) | 40 mg ($349) |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight | 4731.33 g/mol |
| Purity Grade | ≥99% purity (HPLC & Mass Spectrometry verified) |
| Form & Appearance | White lyophilized powder |
| Primary Category | Metabolic |
| Primary Research Focus | Triple agonist (GLP-1R/GIPR/GCGR), energy expenditure, fat oxidation |
| Storage Instructions | Lyophilized: -20°C (Long-term) | Reconstituted: 2°C–8°C |

Reviews
There are no reviews yet.